FTC BACKS DIRECT-TO-CONSUMER DRUG STUDY

By Published on .

WASHINGTON (AdAge.com) -- The Federal Trade Commission is urging the Food and Drug Administration to expand a planned study of the effects of direct-to-consumer drug advertising.

In comments filed with the Office of Management and Budget, the FTC said it supported the FDA's study, calling it "critical to our understanding of the role of advertising ... on consumer welfare."

The FTC also urged that the study include questions that could indicate whether the advertising is lowering the cost of drugs to consumers and how it is affecting insurance coverage.

In this article:
Most Popular